{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T18:25:33Z","timestamp":1777919133690,"version":"3.51.4"},"reference-count":36,"publisher":"Zhejiang University Press","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31772715"],"award-info":[{"award-number":["31772715"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Zhejiang Univ. Sci. B"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1631\/jzus.b1800211","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T21:30:05Z","timestamp":1547674205000},"page":"39-48","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Interferon-\u03b3 regulates cell malignant growth via the c-Abl\/HDAC2 signaling pathway in mammary epithelial cells","\u03b3 \u5e72\u6270\u7d20\u901a\u8fc7c-Abl\/HDAC2 \u4fe1\u53f7\u901a\u8def\u8c03\u8282\u4e73\u817a\u4e0a \u76ae\u7ec6\u80de\u6076\u6027\u751f\u957f"],"prefix":"10.1631","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1638-9343","authenticated-orcid":false,"given":"Wen-bo","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-jing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-fei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-yi","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-hao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian-cheng","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"635","published-online":{"date-parts":[[2019,2,18]]},"reference":[{"issue":"12","key":"323_CR1","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.1096\/fj.09-138412","volume":"23","author":"TM Allington","year":"2009","unstructured":"Allington TM, Galliher-Beckley AJ, Schiemann WP, 2009. Activated Abl kinase inhibits oncogenic transforming growth factor-\u03b2 signaling and tumorigenesis in mammary tumors. Faseb J, 23(12):4231\u20134243. \n                    https:\/\/doi.org\/10.1096\/fj.09-13841.","journal-title":"Faseb J"},{"issue":"6","key":"323_CR2","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.molonc.2012.07.003","volume":"6","author":"B Barneda-Zahonero","year":"2012","unstructured":"Barneda-Zahonero B, Parra M, 2012. Histone deacetylases and cancer. Mol Oncol, 6(6):579\u2013589. \n                    https:\/\/doi.org\/10.1016\/j.molonc.2012.07.003","journal-title":"Mol Oncol"},{"issue":"5","key":"323_CR3","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.3168\/jds.2010-3859","volume":"94","author":"S Bougarn","year":"2011","unstructured":"Bougarn S, Cunha P, Gilbert FB, et al., 2011. Technical note: validation of candidate reference genes for normalization of quantitative PCR in bovine mammary epithelial cells responding to inflammatory stimuli. J Dairy Sci, 94(5): 2425\u20132430. \n                    https:\/\/doi.org\/10.3168\/jds.2010-385.","journal-title":"J Dairy Sci"},{"issue":"19","key":"323_CR4","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1242\/jcs.039859","volume":"122","author":"WD Bradley","year":"2009","unstructured":"Bradley WD, Koleske AJ, 2009. Regulation of cell migration and morphogenesis by Abl-family kinases: emerging mechanisms and physiological contexts. J Cell Sci, 122(19):3441\u20133454. \n                    https:\/\/doi.org\/10.1242\/jcs.039859","journal-title":"J Cell Sci"},{"issue":"5","key":"323_CR5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/intimm\/dxp027","volume":"21","author":"H Brightbill","year":"2009","unstructured":"Brightbill H, Schlissel MS, 2009. The effects of c-Abl mutation on developing B cell differentiation and survival. Int Immunol, 21(5):575\u2013585. \n                    https:\/\/doi.org\/10.1093\/intimm\/dxp027","journal-title":"Int Immunol"},{"issue":"8","key":"323_CR6","doi-asserted-by":"publisher","first-page":"9888","DOI":"10.2174\/156800909790192392","volume":"9","author":"A Carpi","year":"2009","unstructured":"Carpi A, Nicolini A, Antonelli A, et al., 2009. Cytokines in the management of high risk or advanced breast cancer: an update and expectation. Curr Cancer Drug Tar, 9(8): 9888\u20139903. \n                    https:\/\/doi.org\/10.2174\/156800909790192392","journal-title":"Curr Cancer Drug Tar"},{"issue":"S6","key":"323_CR7","doi-asserted-by":"publisher","first-page":">S188","DOI":"10.1111\/1523-1747.ep12875512","volume":"95","author":"ET Creagan","year":"1990","unstructured":"Creagan ET, Schaid DJ, Ahmann DL, et al., 1990. Disseminated malignant melanoma and recombinant interferon: analysis of seven consecutive phase II investigations. J Invest Dermatol, 95(S6): S188\u2013S192. \n                    https:\/\/doi.org\/10.1111\/1523-1747.ep12875512","journal-title":"J Invest Dermatol"},{"issue":"1","key":"323_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.molcel.2014.08.013","volume":"56","author":"M Gonzalez-Zu\u00f1iga","year":"2014","unstructured":"Gonzalez-Zu\u00f1iga M, Contreras PS, Estrada LD, et al., 2014. c-Abl stabilizes HDAC2 levels by tyrosine phosphorylation repressing neuronal gene expression in Alzheimer\u2019s disease. Mol Cell, 56(1):163\u2013173. \n                    https:\/\/doi.org\/10.1016\/j.molcel.2014.08.013","journal-title":"Mol Cell"},{"issue":"3","key":"323_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00253-007-0911-2","volume":"75","author":"C Hildmann","year":"2007","unstructured":"Hildmann C, Riester D, Schwienhorst A, 2007. Histone deacetylases\u2014an important class of cellular regulators with a variety of functions. Appl Microbiol Biotechnol, 75(3):487\u2013497. \n                    https:\/\/doi.org\/10.1007\/s00253-007-0911-2","journal-title":"Appl Microbiol Biotechnol"},{"issue":"9","key":"323_CR10","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1346-8138.1995.tb03889.x","volume":"22","author":"T Horikoshi","year":"1995","unstructured":"Horikoshi T, Fukuzawa KF, Hanada N, et al., 1995. In vitro comparative study of the antitumor effects of human interferon-\u03b1, \u03b2 and \u03b3 on the growth and invasive potential of human melanoma cells. J Dermatol, 22(9):631\u2013636. \n                    https:\/\/doi.org\/10.1111\/j.1346-8138.1995.tb03889","journal-title":"J Dermatol"},{"issue":"13","key":"323_CR11","doi-asserted-by":"publisher","first-page":"7556","DOI":"10.1073\/pnas.95.13.7556","volume":"95","author":"DH Kaplan","year":"1998","unstructured":"Kaplan DH, Shankaran V, Dighe AS, et al., 1998. Demonstration of an interferon \u03b3-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci USA, 95(13):7556\u20137561. \n                    https:\/\/doi.org\/10.1073\/pnas.95.13.7556","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"323_CR12","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.tips.2009.09.007","volume":"30","author":"OH Kr\u00e4mer","year":"2009","unstructured":"Kr\u00e4mer OH, 2009. HDAC2: a critical factor in health and disease. Trends Pharmacol Sci, 30(12):647\u2013655. \n                    https:\/\/doi.org\/10.1016\/j.tips.2009.09.007","journal-title":"Trends Pharmacol Sci"},{"issue":"13","key":"323_CR13","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1093\/emboj\/cdg315","volume":"22","author":"OH Kr\u00e4mer","year":"2003","unstructured":"Kr\u00e4mer OH, Zhu P, Ostendorff HP, et al., 2003. The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J, 22(13): 3411\u20133420. \n                    https:\/\/doi.org\/10.1093\/emboj\/cdg315","journal-title":"EMBO J"},{"key":"323_CR14","doi-asserted-by":"publisher","first-page":"14896","DOI":"10.1038\/srep14896","volume":"5","author":"J Matsuzaki","year":"2015","unstructured":"Matsuzaki J, Tsuji T, Luescher IF, et al., 2015. Direct tumor recognition by a human CD4+ T-cell subset potently mediates tumor growth inhibition and orchestrates antitumor immune responses. Sci Rep, 5:14896. \n                    https:\/\/doi.org\/10.1038\/srep14896","journal-title":"Sci Rep"},{"issue":"1","key":"323_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/ijms19010089","volume":"19","author":"M Mojic","year":"2018","unstructured":"Mojic M, Takeda K, Hayakawa Y, 2018. The dark side of IFN-\u03b3: its role in promoting cancer immunoeevasion. Int J Mol Sci, 19(1):89. \n                    https:\/\/doi.org\/10.3390\/ijms19010089","journal-title":"Int J Mol Sci"},{"issue":"14","key":"323_CR16","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1101\/gad.1563807","volume":"21","author":"RL Montgomery","year":"2007","unstructured":"Montgomery RL, Davis CA, Potthoff MJ, et al., 2007. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Gene Dev, 21(14): 1790\u20131802. \n                    https:\/\/doi.org\/10.1101\/gad.1563807","journal-title":"Gene Dev"},{"key":"323_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/1471-2407-13-215","volume":"13","author":"BM M\u00fcller","year":"2013","unstructured":"M\u00fcller BM, Jana L, Kasajima A, et al., 2013. Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer-overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression. BMC Cancer, 13:215. \n                    https:\/\/doi.org\/10.1186\/1471-2407-13-21.","journal-title":"BMC Cancer"},{"issue":"4","key":"323_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/BF00173511","volume":"4","author":"HB Muss","year":"1986","unstructured":"Muss HB, Caponera M, Zekan PJ, et al., 1986. Recombinant gamma interferon in advanced breast cancer: a phase II trial. Invest New Drugs, 4(4):377\u2013381. \n                    https:\/\/doi.org\/10.1007\/BF00173511","journal-title":"Invest New Drugs"},{"issue":"4","key":"323_CR19","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/hep.20878","volume":"42","author":"SW Nam","year":"2005","unstructured":"Nam SW, Park JY, Ramasamy A, et al., 2005. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling. Hepatology, 42(4): 809\u2013818. \n                    https:\/\/doi.org\/10.1002\/hep.20878","journal-title":"Hepatology"},{"issue":"11","key":"323_CR20","doi-asserted-by":"publisher","first-page":"e28103","DOI":"10.1371\/journal.pone.0028103","volume":"6","author":"JH Noh","year":"2011","unstructured":"Noh JH, Jung KH, Kim JK, et al., 2011. Aberrant regulation of HDAC2 mediates proliferation of hepatocellular carcinoma cells by deregulating expression of G1\/S cell cycle proteins. PLoS ONE, 6(11):e28103. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0028103","journal-title":"PLoS ONE"},{"issue":"2","key":"323_CR21","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.yexcr.2018.05.003","volume":"368","author":"WB Ren","year":"2018","unstructured":"Ren WB, Li Y, Xia XJ, et al., 2018. Arginine inhibits the malignant transformation induced by interferon-gamma through the NF-\u03baB-GCN2\/eIF2\u03b1 signaling pathway in mammary epithelial cells in vitro and in vivo. Exp Cell Res, 368(2):236\u2013247. \n                    https:\/\/doi.org\/10.1016\/j.yexcr.2018.05.003","journal-title":"Exp Cell Res"},{"issue":"1","key":"323_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/eji.201242735","volume":"43","author":"D Sarhan","year":"2013","unstructured":"Sarhan D, D'Arcy P, Wennerberg E, et al., 2013. Activated monocytes augment TRAIL-mediated cytotoxicity by human NK cells through release of IFN-\u03b3. Euro J Immunol, 43(1):249\u2013257. \n                    https:\/\/doi.org\/10.1002\/eji.201242735","journal-title":"Euro J Immunol"},{"issue":"1","key":"323_CR23","first-page":"29","volume":"2","author":"JH Schiller","year":"1996","unstructured":"Schiller JH, Pugh M, Kirkwood JM, et al., 1996. Eastern cooperative group trial of interferon gamma in metastatic melanoma: an innovative study design. Clin Cancer Res, 2(1):29\u201336.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"323_CR24","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.devcel.2010.08.012","volume":"19","author":"CM Trivedi","year":"2010","unstructured":"Trivedi CM, Zhu WT, Wang QH, et al., 2010. Hopx and Hdac2 interact to modulate Gata4 acetylation and embryonic cardiac Myocyte proliferation. Dev Cell, 19(3):450\u2013459. \n                    https:\/\/doi.org\/10.1016\/j.devcel.2010.08.012","journal-title":"Dev Cell"},{"issue":"7","key":"323_CR25","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1128\/MCB.01454-13","volume":"34","author":"JYJ Wang","year":"2014","unstructured":"Wang JYJ, 2014. The capable ABL: what is its biological function? Mol Cell Biol, 34(7):1188\u20131197. \n                    https:\/\/doi.org\/10.1128\/MCB.01454-1.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"323_CR26","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/sj.bjc.6604199","volume":"98","author":"W Weichert","year":"2008","unstructured":"Weichert W, R\u00f6ske A, Gekeler V, et al., 2008. Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy. Br J Cancer, 98(3):604\u2013610. \n                    https:\/\/doi.org\/10.1038\/sj.bjc.6604199","journal-title":"Br J Cancer"},{"issue":"5","key":"323_CR27","doi-asserted-by":"publisher","first-page":"410","DOI":"10.14348\/molcells.2016.2358","volume":"39","author":"XJ Xia","year":"2016","unstructured":"Xia XJ, Che YY, Gao YY, et al., 2016a. Arginine supplementation recovered the IFN-\u03b3-mediated decrease in milk protein and fat synthesis by inhibiting the GCN2\/eIF2\u03b1 pathway, which induces autophagy in primary bovine mammary epithelial cells. Mol Cell, 39(5):410\u2013417. \n                    https:\/\/doi.org\/10.14348\/molcells.2016.2358","journal-title":"Mol Cell"},{"key":"323_CR28","doi-asserted-by":"publisher","first-page":"15065","DOI":"10.1038\/cddiscovery.2015.65","volume":"2","author":"XJ Xia","year":"2016","unstructured":"Xia XJ, Gao YY, Zhang J, et al., 2016b. Autophagy mediated by arginine depletion activation of the nutrient sensor GCN2 contributes to interferon-\u03b3-induced malignant transformation of primary bovine mammary epithelial cells. Cell Death Discov, 2:15065. \n                    https:\/\/doi.org\/10.1038\/cddiscovery.2015.65","journal-title":"Cell Death Discov"},{"issue":"3","key":"323_CR29","doi-asserted-by":"publisher","first-page":"e2138","DOI":"10.1038\/cddis.2016.48","volume":"7","author":"XJ Xia","year":"2016","unstructured":"Xia XJ, Che YY, Zhang J, et al., 2016c. Diet-driven interferon-\u03b3 enhances malignant transformation of primary bovine mammary epithelial cells through nutrient sensor GCN2-activated autophagy. Cell Death Dis, 7(3):e2138. \n                    https:\/\/doi.org\/10.1038\/cddis.2016.48","journal-title":"Cell Death Dis"},{"issue":"5","key":"323_CR30","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1101\/gad.552310","volume":"24","author":"T Yamaguchi","year":"2010","unstructured":"Yamaguchi T, Cubizolles F, Zhang Y, et al., 2010. Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression. Genes Dev, 24(5):455\u2013469. \n                    https:\/\/doi.org\/10.1101\/gad.552310","journal-title":"Genes Dev"},{"issue":"19","key":"323_CR31","doi-asserted-by":"publisher","first-page":"6118","DOI":"10.1158\/1078-0432.CCR-11-0482","volume":"17","author":"MR Zaidi","year":"2011","unstructured":"Zaidi MR, Merlino G, 2011. The two faces of interferon-\u03b3 in cancer. Clin Cancer Res, 17(19):6118\u20136124. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-048.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"323_CR32","doi-asserted-by":"publisher","first-page":"e29416","DOI":"10.1371\/journal.pone.0029416","volume":"7","author":"HJ Zhao","year":"2012","unstructured":"Zhao HJ, Ho PC, Lo YH, et al., 2012. Interaction of proliferation cell nuclear antigen (PCNA) with c-Abl in cell proliferation and response to DNA damages in breast cancer. PLoS ONE, 7(1):e29416. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0029416","journal-title":"PLoS ONE"},{"issue":"11","key":"323_CR33","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1038\/onc.2013.84","volume":"33","author":"HJ Zhao","year":"2013","unstructured":"Zhao HJ, Chen MS, Lo YH, et al., 2013. The Ron receptor tyrosine kinase activates c-Abl to promote cell proliferation through tyrosine phosphorylation of PCNA in breast cancer. Oncogene, 33(11):1429\u20131437. \n                    https:\/\/doi.org\/10.1038\/onc.2013.84","journal-title":"Oncogene"},{"issue":"3","key":"323_CR34","doi-asserted-by":"publisher","first-page":"e12447","DOI":"10.1111\/cpr.12447","volume":"51","author":"HY Zhou","year":"2018","unstructured":"Zhou HY, Cai Y, Liu DN, et al., 2018. Pharmacological or transcriptional inhibition of both HDAC1 and 2 leads to cell cycle blockage and apoptosis via p21Waf1\/Cip1 and p19INK4d upregulation in hepatocellular carcinoma. Cell Proliferat, 51(3):e12447. \n                    https:\/\/doi.org\/10.1111\/cpr.12447","journal-title":"Cell Proliferat"},{"key":"323_CR35","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","volume":"28","author":"JF Zhu","year":"2010","unstructured":"Zhu JF, Yamane H, Paul WE, 2010. Differentiation of effector CD4 T cell populations. Annu Rev Immunol, 28:445\u2013489. \n                    https:\/\/doi.org\/10.1146\/annurev-immunol-030409-10121.","journal-title":"Annu Rev Immunol"},{"issue":"21","key":"323_CR36","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1002\/cncr.28869","volume":"120","author":"H Zuo","year":"2014","unstructured":"Zuo H, Tell GS, Vollset SE, et al., 2014. Interferon-\u03b3-induced inflammatory markers and the risk of cancer: the hordaland health study. Cancer, 120(21):3370\u20133377. \n                    https:\/\/doi.org\/10.1002\/cncr.28869","journal-title":"Cancer"}],"container-title":["Journal of Zhejiang University-SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1631\/jzus.B1800211\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B1800211.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B1800211.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T10:27:02Z","timestamp":1582021622000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1631\/jzus.B1800211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["323"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b1800211","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"value":"1673-1581","type":"print"},{"value":"1862-1783","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"7 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}